Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.
Equilibre has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.
Equilibre's investors include Third Point Ventures.
Equilibre is headquartered in New York, United States.
Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.
Equilibre is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Equilibre — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/equilibre. Accessed August 16, 2026.
VCBacked. (2022). Equilibre — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/equilibre
{{cite web |title=Equilibre — Funding & Investors |url=https://www.vcbacked.co/company/equilibre |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated